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Abstract: Borderline personality disorder (BPD) is a cluster B personality disorder. It is characterized 
by erratic behaviors, emotional instability and one of its hallmarks is self injurious behavior, which 
starts in adolescence. Patients with BPD are difficult to treat, most have a history of child sexual 
abuse, about a quarter present with sexual abuse from a caretaker. Although personality disorders are 
diagnosed only in adults, BPD manifests itself in adolescence in the form of uncontrollable anger, self 
mutilations, dissociation and other such behaviors. Hence, there is a growing number of scientists 
discussing the possibility of diagnosing BPD in adolescents. Here, we give an overview of the history 
and development of BPD in general; and in the adolescent population in particular. We also touch 
upon pharmacological and clinical interventions available for patients being diagnosed and/or 
possessing traits ofBPD. 
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INTRODUCTION 
The diagnosis of borderline personality 
disorder (BPD) has been used for over 30 
years to label patients who are "hopeless", 
those who get therapists upset, and is one of 
the most controversial diagnoses in 
psychology today. The term borderline 
came into existence because such patients 
were believed to lie on the borderline 
between psychosis and neurosis, w ith the 
label "borderline" first coined by Adolph 
Stern in 193 8 ( 1 ). Although the advent of 
this disorder was in 193 8, it was not until 
1980 when it was accepted as a 
psychological term and included in the 
DSM III (Diagnostic and Statistical Manual 
III) (2) and later as a cluster B personality 
disorder, together with histrionic, antisocial, 
and narcissistic personality disorders (3). 
The most general description of borderline 
personality is given by Kernberg (4), 
whereas the most scientific description is 
by Gunderson (5). The diagnostic interview 
for BPD was developed by Gunderson, 
Kolb, and Zanarini (6). 
The most prominent view and studies 
today come from Marsha Linehan, who has 
developed a special therapy for BPD (7). 
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Linehan's sociobiological theory rests on 
the knowledge that people with BPD are 
born with a tendency to react more 
intensely to lower levels of stress and take a 
longer time to recover and seem to be 
raised in invalidating environments (7). 
BPD patients often view themselves as 
helpless victims in a dangerous world, and 
that they are unacceptable in society. They 
are known to have reduced "facial expres-
siveness" (8), as well as a great need of 
nurturance and self-assurance. The chaos 
that characterizes borderline patients makes 
them difficult cases for therapists. A patient 
with BPD may be continuously suicidal for 
months or years. Moreover, many of the 
same problems that patients have with other 
people arise in their relationships with 
helping professionals (7). 
In I Hate You -- Don't Leave Me! (9), 
whose name is consistent with the clinging 
and distancing behaviors (9) of the border-
line, the authors refer to BPD as 
"emotional hemophilia; [a borderline} 
lacks the clotting mechanism needed to 
moderate his spurts of feeling. Stimulate 
a passion, and the borderline emotionally 
bleeds to death. " 
Persons with BPD have a very hard time 
controlling their emotions and may feel 
ruled by them. Marsha Linehan (10) said, 
"People with BPD are like people with 
third degree burns over 90% of their 
bodies. Lacking emotional skin, they feel 
agony at the slightest touch or movement. " 
Borderline personality was often confused 
with histrionic personality disorder, paranoid 
personality disorder, antisocial personality 
disorder, and dependent personality disorder 
(3, ll ). Histrionic personality disorder can 
also be characterized by attention seeking, 
manipulative behavior, and rapidly shifting 
emotions just like BPD, but in BPD there is 
self-destructiveness, angry disruptions in 
close relationships, and chronic feelings of 
deep emptiness and loneliness (3,5,6). 
Paranoid personality disorder can be 
characterized by an angry reaction to minor 
stimuli, but the stability of self-image and 
lack of self-destructiveness, impulsivity, 
and abandonment concerns distinguishes it 
from BPD (3). As for antisocial personality 
disorder, individuals are often manipulative 
to gain profit or power, whereas in BPD 
their main goal is to gain the attention and 
nurturance of a caregiver (3). In contrast to 
dependent personality disorder, people with 
BPD react to abandonment with feelings of 
emotional emptiness, and rage and incon-
sistent relationships (3). 
EPIDEMIOLOGY 
About 3% of the population suffers from 
BPD (12). Additionally, BPD is the most 
common personality disorder seen in 
clinics, in fact, it accounts for more than 
50% in certain clinical settings (13). In 
another resource, BPD is diagnosed in 10% 
of psychiatric outpatients and about 20% of 
inpatients (14). The disorder is more prev-
alent in women than in men, in fact 76% of 
borderline patients are women ( 15). The 
American Psychiatric Association (APA) 
specifies that 1.5% to 2.5% of the adult 
population has BPD, but in specific clinical 
populations it encompasses about 50% (3): 
ETIOLOGY 
Most patients with BPD have some sort of 
physical or sexual abuse history, as well as . 
dysfunctional family dynamics. In reality, 
about a quarter to 30% of the patients. 
present with a history of sexual abuse from . 
a caretaker and a third report severe forms 
of abuse ( 1, 16). Sexual abuse seen in BPD • 
patients tends to happen at a very early age . 
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( 17). The high rates of child sexual abuse 
presence in this group led many investi-
gators to wonder whether this condition is 
another form of post traumatic stress disorder 
(PTSD) ( 16). Investigators believing in this 
notion tend to focus on unraveling the past. 
However, no evidence has be presented 
showing that these methods are successful. 
In fact, there is some reason to suspect they 
can make patients worse, by focusing too 
much on the past and not enough on the 
present. In addition, borderline patients in 
psycho-therapy are particularly prone to 
develop false memories ( 16). 
Although it forms a risk factor, child 
abuse is not specific to BPD (1, 16). This 
view is consistent with the knowledge that 
adverse life events and environments are 
not pathogenic but rather produce a set of 
symptoms in vulnerable populations. The 
usual borderline environ-ment involves a 
largely absent father and a depressed or 
erratic mother, in an invalid-dating environ-
ment. Thus, the etiology of the disorder is 
dominated by views of traumatic childhood 
experiences, disorganized attachment, and 
punitive or inappropriate rearing styles 
(8,16). 
In general, BPD is associated with 
deranged family environments that are 
usually characterized by the separation of 
parents, inappropriate rearing styles, and 
lack of loving care. No single factor has 
been involved in the development of BPD, 
instead, it is believed that several factors 
(Biological, social, psychological) inter-
connect and play a role in the development 
of BPD (I). There has been evidence 
though, that inpatients with BPD have more 
lifetime co-morbid axis I disorders than do 
patients with other personality disorders 
(18). BPD creates enormous suffering in 
those afflicted with it. Most patients 
describe a continuous state of emotional 
chaos, swinging from extremes of 
depression, anger, and anxiety. Borderline 
patients often need to feel suicidal to know 
that they can escape from their dysphoric 
feelings , and this feeling actually seems to 
give them a sense of reassurance that there 
is a way out if all fails ( 1 ). 
BIOLOGICAL FACTORS 
Many personality disorders have been 
associated with dysfunction of the serotonin 
system, particularly traits of aggression and 
impulsivity (19). Abnormal dopamine, sero-
tonin, acetylcholine, monamine oxidase, 
HPA (hypothalamic pituitary axis) hormones, 
or thyrotrophic releasing hormone activity 
(16) are seen in different personality 
disorders. Studies showed a decrease in the 
level of the serotonin metabolite 5 hydroxy-
indole acetic acid in the cerebrospinal fluid 
of BPD patient as well as in their platelets. 
There seems to also be a reduction in the 
platelet paroxetine binding in BPD patients 
compared with the normal population, 
which may reflect a dysfunction in the pre-
synaptic serotonin (20). In addition, sub-
components of the cingulated cortex 
representing the functions of emotion and 
attention processing are markedly decreased 
in BPD patients, especially the right 
anterior cingulated, with reduced gray 
matter compared with normal (21 ,22) 
One of the co-morbid disorders with 
BPD is major depressive disorder (MOD); 
rates can reach as high as 85% (23). 
Patients with MDD and BPD had elevated 
cortisol and pro-inflammatory cytokines 
compared with the healthy group (23). 
Heritable factors play more than half of the 
trait variability in this disorder. Studies 
conducted in twins support the notion of a 
heritable component, especially in traits 
involving impulsivity and instability (I). 
Even though most patients with BPD 
exhibit a deficit in central serotonergic 
functioning, no marker has been found to 
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the overall disorder (1). Thus, BPD seems 
to be a multifactorial personality disorder 
that has biological, social, and psychological 
factors engraved into it. 
COURSE OF DEVELOPMENT 
BPD normally emerges in adolescence, 
becoming most severe around 25 years of 
age. Most BPD patients fail in their 
education and relationships, and suicide 
claims the lives of about l 0%, while most 
engage in self-harm behaviors (8). BPD 
patients' suicidal ideation peaks in the early 
20s, but complete and successful suicide 
attempts are most common in their 30s. Self 
mutilation is often. found in BPD but is not 
usually associated with suicidal intent; 
instead they serve to regulate the emotional 
states that the person might be in (1 ). About 
75% of BPD patients regain normal 
functioning at about 35 years of age, and 
90% after 50 years of age (1 ). The 
mechanism for this improvement is not yet 
known. The level of long term improve-
ment in borderline patients varies a great 
deal. A minority will actually be able to 
lead a successful life with a happy marriage 
and good careers. Once close to middle age, 
most of the patients' impulsivity decreases, 
which leads to a better life (1). 
BPD IN ADOLESCENTS 
Although personality disorders are not 
usually diagnosed in children under the age 
of 18 years, making a diagnosis based on 
several factors presented in childhood is 
possible. Most symptoms and behavior 
patterns appear in adolescence (14,24), 
affecting around 3% of the adolescent 
population, which matches the percentage 
in adults (14). Although according to 
another report, it seems likely that the 
prevalence of this disorder in adolescents is 
much higher (2). Symptoms include fear of 
abandonment, self damaging impulsivity, 
reactivity of mood, and extreme ideation/ 
devaluation, which are similar to adults ~ 
Adolescents being diagnosed with BPD 
also show several co-morbidities, such as 
mood disorders, eating disorders, PTSD, 
ADHD (attention deficit and hyperactivity 
disorder) and others (25). Adolescents 
diagnosed with BPD also seem to have a 
higher rate of date rape and multiple sexual 
partners, indicative of high risk behaviors 
( 17). This behavior complicates and causes 
confusion in the diagnosis of BPD (25). 
The data from one group suggests that 
BPD diagnosis in adolescents was stable 
over a two-year period in only about 33%, 
whereas a different report found that these · 
rates were different between moderate and 
severe BPD. Those exhibiting a moderate 
state of BPD during adolescence showed a 
29% persistence after two years, while 
those with severe BPD showed a 
persistence of 24% (26,27). Nevertheless, it 
seems like the long term presence of axis I 
disorders may be accounted for via . 
personality disorders. Similar to adult 
patients with BPD, adolescents typically .. 
have inconsistent childhood experiences, 
often from the matemal side. Additionally, 
several known behaviors are occurring in 
adolescents that may predict personality . 
disorders of any type; for instance, that · · 
conduct disorders during adolescence may 
lead to the development of antisocial · ·. 
personality disorder is well known (14) . .• 
Another report suggested that traits and · 
patterns of personality are developed· · · 
around the end of preschool, but can still be 
affected by environmental factors later on • · 
in life. For instance, children with attach-
ment issues in preschool years tend to 
become more depressed, use drugs, arid. 
have behavioral problems compared with 
controls (2). In fact, several studies have' · 
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shown that the occurrence of certain 
behaviors during childhood and adolescence, 
such as self mutilation, affective instability, 
and impulsivity, are indicators of and 
predictors of BPD diagnosis later on in life 
(2). Nevertheless, BPD diagnosis in below 
18-year olds should be made with extreme 
caution because adolescence is a dynamic 
stage, thus, the diagnosis and symptoms 
may not stay stable until adulthood (2). 
Likewise, the adult population does not 
show stable BPD symptoms. 
PROS AND CONS FOR DIAGNOSIS OF BPD 
The pros include the fact that this diagnosis 
encompasses a number of symptoms that 
may or may not be diagnosed separately, 
such as the presence of Bulimia, major 
depressive disorder and others, which if 
diagnosed alone may be misleading to the 
treating professional (I). Additionally, there 
is growing data and resources as to what 
methods of treatment would be successful 
in treating BPD, which will be discussed 
next. If BPD is not diagnosed, then the 
treatment of choice might actually be 
harmful for BPD patients. Such results were 
seen when a study was conducted to inspect 
the difference between Dialectical behavior 
therapy (discussed below) and traditional 
Cognitive behavioral therapy (7). Although 
both are a form of cognitive therapy, the 
former strives to achieve acceptance rather 
.than change, whereas the latter focuses 
more on change. 
On the other hand, BPD patients are 
known in the world of psychologists as 
difficult patients to work with, especially 
due to their high drop out rate in therapy as 
well as the increasing 'need' of such . 
patients for their therapists to be there for 
them, in fact the diagnosis of BPD itself is 
highly stigmatizing (14). Such a diagnosis 
may render the patient hopeless. Additionally, 
such a diagnosis may cause the therapists to 
overlook other underlying problems that 
may be misinterpreted as 'results' of BPD. 
TREATMENT 
There is no specific or universal method of 
treatment for BPD. The mainstay of treat-
ment for BPD has always been, and 
continues to be, psychotherapy. Because of 
their impulsivitY, however, about two thirds 
of borderline patients drop out of treatment 
within a few months (7). Those patients 
who stay in therapy will usually improve 
slowly over time. The goal of therapy is to 
reduce the frequency of borderline 
behaviors and allow the person to be more 
adaptive to society. The best therapeutic 
approaches to this disorder are still being 
debated. It appears that establishing a 
trusting relationship with a therapist who 
does not punish borderline symptoms has 
positive results (7,25). The therapist must 
actively participate in the therapeutic process 
by giving the patient constant assurance and 
support while emphasizing the harmful 
effect of drug abuse, promiscuity, or other 
behaviors (7). 
Dialectical behavioral therapy (DBT) 
There are currently three main treatments 
for .BPD patients, the first ·is Transference 
focused therapy, which was first applied by 
Kemberg. This treatment is based on the 
interpretation of object relations activated 
in a therapeutic relationship. The second is 
dialectical behavioral therapy, which focuses 
on acceptance and change. This is so far the 
most widely accepted treatment and thus 
will be discussed in more detail. Lastly, 
supportive psychotherapy which, like the 
first, is based on an object-relational and 
psychm~nalytical view but focuses on patient 
identity development (28). 
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Dialectical behavior therapy (DBT) is a 
form of cognitive behavioral therapy that 
targets affective instability and impulsivity 
using group and individual sessions to 
regulate the patient's ability to handle 
emotions (18). Whether this method of 
treatment is effective in the long run is yet 
to be seen (1 ). It is believed that patients 
with BPD fail to master three main basic 
dialects: 
1. Vulnerability versus invalidation, 
2. Active passivity versus apparent 
competence, 
3. Unremitting crisis versus inhibited 
grief(10). 
Linehan attributed the development of BPD 
to a childhood environment that was 
chronically invalidating about one's self 
and feelings. Thus, BPD patients tend to 
look for proof in their environment and 
people surrounding them for validating 
their feelings ( 18). 
Patieqts in DBT participate in a weekly 
group two-and-a-half-hour session, as well 
as a one-hour individual therapy session. 
This treatment begins with a contract between 
the patient and the therapist for one year, 
which is renewable if improvement is seen. 
Four main sets of skills or modules are 
taught: (1) Core mindfulness, (2) Interper-
sonal effectiveness, (3) Emotion regulation, 
(4) Distress tolerance. The group and 
individual sessions are also supported by 
the presence of phone contact between 
sessions whenever the patient feels distressed 
and has exhausted available skills she/he 
h.as to prevent a harmful behavior. The 
phone contact is primarily to coach and to 
help the patient through his/her moment of 
distress (I ,29). 
The fundamental concept of DBT is 
accepting the patient as he/she is, as well as 
validation of their feelings while working to 
change. Since BPD patients are often seen 
as "hopeless", it is important for therapists 
to engage in weekly group consultations to 
keep the therapist motivated when difficulties 
arise with the patients, as well as to make 
sure that the therapist is adhering to the . 
model presented by DBT (7,29,30). There ' 
must be an open collaboration between the 
therapist and the patient, as well the use of 
extensive self monitoring techniques and 
Zen Buddhism meditation techniques (31). 
There are four main stages when dealing 
with a borderline patient (49) that focus on ' . 
decreasing life threatening and interfering 
behavior, then treating PTSD, after which 
the focus becomes to develop self esteem 
and finally, to secure a good and optimum . . 
experience. The results of DBT confirm 
that patients became inore effective inter-
personally in their relationships, and the 
percentage of hospitalizations dramatically 
decreased (1 , 7 ,29). 
There are a number of limitations for 
DBT, such as the studies were made based 
on a small number of participants. To tell 
whether this kind of therapy is effective for 
everybody with BPD is also very difficult 
because there is a very broad range. 
There seems to be evidence that after a 
year of stopping treatment, the patients with 
BPD and a control group seem to be very 
similar, which might indicate that the 
continuation of therapy for more than one 
year might be important for BPD patients to 
remain at a higher level of healthy func-
tioning (29). DBT had many similarities to 
the Bateman and Fonagy's model, such as 
having an intensive, multimodal, and 
relationship-focused treatment, with easy 
access to the therapjsts (29). Family skills 
training may also be important so that they 
understand the behavioral patterns for 
borderline behavior and enhance the presence 
of a validating environment (28). Never-
theless, Linehan's model seems to shed some 
L AL-ALEM AND HA OMAR 401 
hope in BPD patients that a life worth living 
might actually be achievable (7, 29). 
Pharmacological treatments 
Drugs can take the .edge off impulsive 
symptoms. Short term treatments can 
include anxiolytic or neuroleptic drugs that 
are given for short periods or at times of 
severe stress (32). Long-term treatments 
might involve the use of neuroleptics, 
which can be helpful in cases of paranoid 
and schizoid personality disorders (32,33). 
However, one possibility is that the 
medication is being used to control risk and 
stress rather than having any long-term 
impact on the personality disorder itself. 
Nevertheless, no psychopharmacological 
agent has any specific effect on the 
underlying borderline pathology. Despite 
the association between impulsivity and 
low serotonin activity, specific serotonin 
reuptake inhibitors (such as tluoxetine) 
rarely produce a dramatic improvement. 
Medications have been effective only at 
improving moods and sometimes behavior. 
Doctors are still exploring the effect of 
antidepressants, antipsychotic drugs, and 
anti-anxiety drugs. These medications 
appear to reduce symptoms of impulsivity, 
depression, cognitive impairment, and 
perceptual impairment. Hospitalization may 
be necessary if the person is having suicidal 
thoughts and behaviors. Thus, there seems 
to be no confounding influence of medi-
cation on BPD (18). Noteworthy is that 
although different pharmacologic agents 
reduce the symptoms of BPD, no remission 
ensues. This is a vital point because many 
patients are on four to five agents with the 
understanding that this regimen will ' cure' 
their disorder (1) 
CONCLUSIONS 
Detecting and diagnosing BPD in adole-
scents is possible. Yet, as the diagnosis is 
made based on the presence of five of nine 
criteria, this classification le ads to a vast 
heterogeneity of diagnosis, whether in adol-
escents or.adults (I). Because the symptoms 
seen in BPD. are found in other disorders, it 
is common for patients to be diagnosed by 
the symptoms · (for example, Anxiety 
disorder) rather than BPD, which as a result 
goes undetected (1 ) . In addition, due to the 
mood swings the borderline might have, the 
diagnosis may be mistaken for · bipolar 
disorder, the difference would be that BPD 
patients do not experience a continuous 
elevated mood, but instead exhibit rapid 
shifts that may only last for minutes or 
hours (I). 
To give a diagnosis, there has to be a 
consistent pattern of affective instability, 
impulsivity, and unstable relationships (1 ). 
DSM IV-TR (Diagnostic and Statistical 
Manual IV-Text revision) (3) presents more 
comorbidity and positive diagnosis in person-
ality disorders compared with International 
Classification of Disease-! 0 (lCD 1 0). Yet, 
with regard to BPD, lCD 10 subdivides the 
disorder into 2 subcategories, hence the 
patient gets a different diagnosis based on 
what subcategory he/she meets. It is 
important for the World Health Organi-
zation (WHO) and the APA to unite their 
categories and diagnostic criteria (34). 
Bad prognosis was seen when a patient 
has alcohol abuse, antisocial and schizoid 
elements, and hostility with depressive and 
anxious features. On the other hand good 
prognosis was seen in those with a high IQ, 
talent, high attractiveness, and likeability 
(19,35). There are also investigations that 
proved that BPD is indeed a maladaptive 
personality trait based on the relatively new 
Five Factor Model (36). More research must 
be done on the causes of BPD to develop 
more-rational methods of treatment. In the 
'future, we will probably have methods of 
pharmacotherapy and psychotherapy that are 
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specifically designed for this challenging 
patient population. In the meantime, the best 
hope for most patients consists of linking up 
with a good therapist who is reliable and 
experienced ii1 at least one of the main 
psychotherapy models that are currently 
available for borderline personality disorder. 
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